GSK plc (LON: GSK)

Market Cap	55.25B
Revenue (ttm)	31.31B
Net Income (ttm)	2.51B
Shares Out	4.08B
EPS (ttm)	0.61
PE Ratio	22.27
Forward PE	8.44
Dividend	0.58 (4.27%)
Ex-Dividend Date	Nov 14, 2024

Volume	3,752,640
Average Volume	6,144,080
Open	1,356.50
Previous Close	1,359.00
Day's Range	1,352.00 - 1,369.32
52-Week Range	1,282.50 - 1,823.50
Beta	0.33
RSI	53.99
Earnings Date	Jan 31, 2025

About GSK plc

GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, and specialty and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through two segments, Commercial Operations and Total R&D. The company offers shingles, meningitis, respiratory syncytial virus, flu, polio, influenza, and pandemic vaccines. It also provides medicines for HIV, oncology, respiratory/immunology, and other specialty medicine products, as well as inhaled...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1715
• Employees: 70,212
• Stock Exchange: London Stock Exchange
• Ticker Symbol: GSK

Financial Performance

In 2023, GSK plc's revenue was 30.33 billion, an increase of 3.42% compared to the previous year's 29.32 billion. Earnings were 4.93 billion, a decrease of -67.05%.